Physician profile
Paul Gagne
NPI 1942294772
$765,736.38
in general payments reported to CMS, 2019-2025
46 companies · $77K in 2025
The $77K reported for 2025 was more than what 99% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $145K · 2020: $102K · 2021: $95K · 2022: $119K · 2023: $113K · 2024: $114K · 2025: $77K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $144K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $110K · Honoraria: $21K · Food and Beverage: $15K · Travel and Lodging: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $143,649.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $109,920.00 |
| Honoraria | $21,125.00 |
| Food and Beverage | $15,214.24 |
| Travel and Lodging | $14,179.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $306,829.48 | 2019-2025 | (9520) Igt Devices Undivided, Igt Devices Undivided, (6554) Peripheral Vascular Undivided |
| Cook Incorporated | $234,399.67 | 2019-2025 | Zilver Vena, Zilver 518, Cook Celect |
| Medtronic, INC. | $85,977.26 | 2021-2025 | Abre, Hawkone, Venaseal |
| Boston Scientific Corporation | $67,143.29 | 2019-2023 | Varithena Administration Pack |
| Endologix LLC | $18,127.67 | 2022-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| Cook Medical LLC | $11,338.31 | 2019-2025 | Cook, Zilver Vena, Zilver Ptx |
| Cook Research Incorporated | $11,270.45 | 2019-2025 | Zilver Vena, Profusion Therapeutic Infusion Needle |
| W. L. Gore & Associates, INC. | $7,322.43 | 2023-2025 | Product In Development, Gore Viabahn Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft |
| Vesper Medical | $6,872.98 | 2021 | |
| Provisio Medical, INC. | $3,674.43 | 2019-2024 | |
| Hydrocision, INC. | $2,625.00 | 2021 | |
| Medtronic Vascular, INC. | $2,531.35 | 2019-2020 | |
| Mercator Medsystems, INC. | $1,375.88 | 2021-2024 | Leapfrog Micro-Infusion Device, Bullfrog |
| Bard Peripheral Vascular, INC. | $866.39 | 2019-2023 | Lifestar Biliary Stent |
| Inari Medical, INC. | $791.74 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $729.40 | 2021-2024 | Peripheral Vascular |
| Argon Medical Devices, INC. | $600.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $321.67 | 2019-2024 | Xarelto |
| Tactile Systems Technology INC | $299.19 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Cordis US Corp. | $258.82 | 2022-2025 | Selution Slr Pta, Radial 360 |
| Silk Road Medical, INC. | $236.57 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Veryan Medical Incorporated | $225.69 | 2021-2025 | Biomimics 3d Vascular Stent System |
| E.R. Squibb & Sons, L.L.C. | $222.29 | 2019-2025 | Eliquis |
| Biocompatibles, INC. | $214.64 | 2019 | |
| Smith+Nephew, INC. | $182.51 | 2019-2025 | Grafix Pl, Stravix, Renasys Touch |
| Bolton Medical INC | $171.35 | 2022-2024 | Treo Abdominal Stent-Graft System |
| Abbott Laboratories | $164.43 | 2019-2025 | Diamondback Peripheral, Esprit, Supera |
| Abbvie INC. | $150.00 | 2025 | |
| Angiodynamics, INC. | $133.43 | 2019-2023 | Auryon Laser System 100-120 Vac |
| Intervene, INC. | $125.84 | 2025 | Recana Thrombectomy Catheter System |
| Cardiovascular Systems INC. | $90.18 | 2019-2022 | |
| Kerecis Limited | $80.61 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Stryker Corporation | $73.61 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| Organogenesis INC. | $68.84 | 2021-2023 | Puraply |
| Intact Vascular, INC. | $61.58 | 2019 | |
| Reprise Biomedical, INC. | $28.78 | 2023 | Miro3d, Miroderm |
| Bsn Medical INC | $26.23 | 2019 | |
| Covidien Lp | $25.92 | 2019 | |
| Penumbra, INC. | $23.63 | 2023 | Indigo System |
| Lemaitre Vascular, INC. | $19.10 | 2024 | Artegraft Vascular Graft |
| Biotronik INC. | $16.68 | 2023 | Passeo-18, Pulsar-18 T3, Nhancer Rx |
| Baxter Healthcare | $13.15 | 2023 | |
| Z-Medica, LLC | $13.01 | 2019 | |
| Ethicon US, LLC | $12.90 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$24,689.30 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$451,651.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Gagne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.